Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals
CompletedOBSERVATIONAL
Enrollment
3,000
Participants
Timeline
Start Date
June 1, 2015
Primary Completion Date
June 1, 2018
Study Completion Date
January 1, 2019
Conditions
HCC in Chronic HCV Patients With Advanced Liver Fibrosis
Interventions
DRUG
DAAs
lab, U/S, Fibroscan \& CT if needed
All Listed Sponsors
lead
Egyptian Liver Hospital
OTHER
NCT03884062 - Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals | Biotech Hunter | Biotech Hunter